top of page
HALOPV.jpg

Join us for an exciting day filled with engaging and relevant PV-related topics designed to inspire and inform in this FREE one-day convention in Basel.

 

Our agenda will feature insightful sessions from distinguished speakers in the field. Humaira Qureshi, President at Qinecsa will present on "Future Proofing Pharmacovigilance End to End", and Ingelise Bærentzen Melchiorsen Head of Drug Safety & Organizational Change Management at NNIT and Helle von der Recke-Heisel Vice President of Global Drug Safety and QPPV at Pharmacosmos will cover the comprehensive journey from preparation to hypercare, using a real example of a project lifecycle.

We are thrilled to invite you to Insife Annual Convention!

Connect. Collaborate. Community.

Banner image for Insife Annual Convention

Other sessions still in the planning phase will cover advancement of AI in Pharmacovigilance, emerging trends and many other insightful solutions to keep you engaged.

Don't miss this rare opportunity to network and connect with fellow pharmacovigilance professionals who share your passion for advancing the field.

We look forward to seeing you at our annual convention. If you have any questions, please don't hesitate to contact us at hello@insife.com.

To see how it was at last year's convention, please click here.

Event details

Date: 26th September 2024

Time: 09:00*-17:00 CET

Location: Novartis Campus, Basel, Switzerland

*Registration & breakfast start at 08:00 CET

 *By registering for Insife Convention, you agree to allow us to take photos of you and share them on Insife's social media, newsletter, and website. If you wish to withdraw your consent at any time, please send an email to hello@insife.com.

Agenda

08:00 - 09:00

Registration & breakfast

09:00 - 09:30

Jen Markey

CSMO, Insife

Jen Markey, CSMO, Insife

Welcome & Review of the Day

09:30 - 10:00

To be announced

Keynote Presentation

10:00 - 10:30

Martin Holm-Petersen 

CEO, Insife

Martin Holm-Petersen  CEO, Insife

A retrospective review of mistakes and failures in PV technology: what have we learned?

10:30 - 11:00

Coffee break

11:00 - 11:30

To be announced

The future of PV, predictions for 2030 and beyond

11:30 - 12:00

Humaira Qureshi

President Qinecsa

Humaira Qureshi  President Qinecsa

Future Proofing Pharmacovigilance End to End

12:00 - 13:00

Lunch

13:00 - 13:30

MHRA

Innovating Patient Safety, a regulators perspective

13:30 - 14:00

Ingelise Bærentzen Melchiorsen

Head of Drug Safety, NNIT with

Helle von der Recke-Heisel,

Vice President of Global Drug Safety

and QPPV, Pharmacosmos

Ingelise Bærentzen Melchiorsen  Head of Drug Safety, NNIT

The journey from preparation to hypercare when moving to a new PV system

14:00 - 14:30

Speed Networking

14:30 - 15:00

Coffee break

15:00 - 15:30

Louise Tan

Head of GRIP Services, Insife

Louise Tan  Head of GRIP Services, Insife

Getting a GRIP on Regulatory Intelligence

15:30 - 16:00

To be announced

The AI Journey: Pitfalls and Successes

16:00 - 16:30

To be announced

Advances in automated AE ingestion and translation

16:30 - 17:00

Closing ceremony

 *By registering for Insife Convention, you agree to allow us to take photos of you and share them on Insife's social media, newsletter, and website. If you wish to withdraw your consent at any time, please send an email to hello@insife.com.

Speakers

Martin Holm-Petersen  CEO, Insife

Martin Holm-Petersen, CEO Insife

Executive leader with 10 years of experience within the pharma industry and another 10+ years in consulting. Martin is an experienced manager and strategist, with understanding across the pharma business value chain, and an expert on Pharmacovigilance. His current role is CEO of Insife, a global technology and consulting company. In this capacity, digital transformation is central to Martin’s engagements with Industry and Regulatory Agencies.

The upcoming online event will delve into topics of innovation in case intake, exploring the different approaches to technology, featuring insights from industry experts, and examining the integration of AI within intake processes and the diverse approaches to tackling this challenge.

Presentation name: A retrospective review of mistakes and failures in PV technology: what have we learned?

Humaira Qureshi  President Qinecsa

Humaira Qureshi, President, Qinecsa

Humaira has over 20 years’ strategic and operational experience in clinical and post-marketing drug safety solutions. As President of Qinecsa, Humaira is spearheading a movement to bring together scientific expertise with technology and create world-leading solutions that address the challenges faced by the pharmacovigilance industry and advance drug safety solutions to the next level of innovation, expertise and customer excellence. Prior to 2022 Humaira led a number of global pharmacovigilance businesses, delivering growth through customer excellence she has implemented sustainable operating models to support and manage future-proof PV operational solutions for many clients which include Regulatory Agencies.

 

Humaira has a bachelor's degree in Medicinal Biochemistry from Royal Holloway, University of London and a diploma in leadership and artificial intelligence from the Said Business School, University of Oxford. She is frequently invited to lecture, having presented on a range of pharmacovigilance topics at industry and academic events in the US, EU, and Asia, and has participated on a number of Global PV forums focusing on technology, sourcing, and process enablement.

Presentation name: Future Proofing Pharmacovigilance End to End

Louise Tan  Head of GRIP Services, Insife

Louise Tan, Principal PV Consultant and Head of GRIP Services, Insife

Louise is a PV subject matter expert with 15+ years of experience within Industry, consulting, PV network leadership and project management, combining deep domain knowledge with strong presentation, facilitation and problem-solving skills. She joined Insife in December 2022 with an aim to expand her horizons in the PV tech ecosystem and works with both Industry and Regulators to implement game changing technologies. Louise currently leads our Global Regulatory Intelligence Club for Pharmacovigilance (GRIP).

Presentation name: Getting a GRIP on Regulatory Intelligence

Ingelise Bærentzen Melchiorsen  Head of Drug Safety, NNIT

Ingelise Bærentzen Melchiorsen, Head of Drug Safety & Organizational Change Management at NNIT

Ingelise Melchiorsen is Head of Drug Safety & Digital Adoption in NNIT, a global IT service provider to the pharmaceutical industry. Ingelise has 10+ years of experience across Pharma & MedTech. She advises global pharmaceutical companies on their digital transformation with strong focus on Drug Safety and how to successfully lead the people through the change.

Presentation name: The journey from preparation to hypercare when moving to a new PV system

bottom of page